Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Giacoletti

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|November 1, 2014
A quality by design approach for longitudinal quality attributesPierre Lebrun, Katherine Giacoletti, Tara Scherder, et al.
Journal of Applied Statistics|September 13, 2024
A Bayesian approach for evaluating equivalence over multiple groups, and comparison with frequentist tostJos Weusten, Ji Young Kim, Katherine Giacoletti, et al.
Vaccine|July 13, 2004
Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy womenKenneth H Fife, Cosette M Wheeler, Laura A Koutsky, et al.
Vaccine|May 15, 2007
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccineSven-Eric Olsson, Luisa L Villa, Ronaldo L R Costa, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|November 1, 2014
A quality by design approach for longitudinal quality attributesPierre Lebrun, Katherine Giacoletti, Tara Scherder, et al.
Journal of Applied Statistics|September 13, 2024
A Bayesian approach for evaluating equivalence over multiple groups, and comparison with frequentist tostJos Weusten, Ji Young Kim, Katherine Giacoletti, et al.
Vaccine|July 13, 2004
Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy womenKenneth H Fife, Cosette M Wheeler, Laura A Koutsky, et al.
Vaccine|May 15, 2007
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccineSven-Eric Olsson, Luisa L Villa, Ronaldo L R Costa, et al.
Pageof 1